North America currently holds majority of the market immuno oncology assays share followed by Europe, while Asia Pacific region is anticipated witness highest growth rate over the forecast period
Dallas, Texas, Nov. 26, 2020 (GLOBE NEWSWIRE) -- The “Global Immuno Oncology Assays Market Size, by Product (Consumables, Software), Technology (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), Indication (Lung Cancer, Colorectal Cancer, Other Cancers), Applications (Research, Clinical Diagnostics), Region and Forecast, 2018 to 2028” study provides an elaborative view of historic, present and forecasted market estimates.
Request a pdf sample at https://www.adroitmarketresearch.com/contacts/request-sample/1603
Adroit Market Research report on global immuno oncology assays market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities, and challenges. The market has been studied for historic years from 2018, with the base year of estimation as 2019 and forecast from 2020 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market competition with Porter's five forces analysis and company positioning based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global immuno oncology assays market have been studied in detail.
Growing cancer prevalence coupled with rising acceptance of targeted therapy to fuel market growth at a CAGR of ~12% from 2020 to 2028. The market growth is driven by growing adoption of targeted therapy over traditional therapy coupled with rising mAbs demand.
Browse the full report with Table of Contents and List of Figures at https://www.adroitmarketresearch.com/industry-reports/immuno-oncology-assays-market
A widespread variety of analytical methods across diverse matrices, including blood cells, tumor, and DNA/RNA, are needed to describe the best, most revealing picture when it comes to immuno-oncology assessments. Options involve testing circulating proteins in the blood using immunoassays; evaluating the blood’s cellular portion, including analyzing circulating tumor cells and/or circulating free DNA by flow cytometry; and PCR expression of tumor genes
North America currently holds the largest share in Immuno Oncology Assays market owing to the presence of significant number of major players across the region along with growing investments by the established firms. Furthermore, Asia Pacific is going to record growth at a faster pace on account of rising awareness levels of cancer, and growing interest of major giants to explore opportunities across emerging economies of India, and China in particular.
Are you looking for a DISCOUNT? If yes, then get in touch with us at https://www.adroitmarketresearch.com/contacts/discount/1603
The scope of the report is segmented into product, technology, indication, applications, and region. Some of the notable players operating across the global immuno oncology assays market includes F. Hoffmann-La Roche Ltd., Abbott, Merck KGaA, Agilent Technologies, Thermo Fisher Scientific, Inc., QIAGEN, bioMérieux SA, Illumina, Inc., PerkinElmer Inc., and Randox Laboratories Ltd. among other prominent players.
Direct purchase the report at https://www.adroitmarketresearch.com/researchreport/purchase/1603
Major Points from Table of Contents:
Chapter 1. Introduction
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. Global Immuno Oncology Assays Market by Product, 2018-2028 (USD Billion)
Chapter 5. Global Immuno Oncology Assays Market by Technology, 2018-2028 (USD Billion)
Chapter 6. Global Immuno Oncology Assays Market by Indication, 2018-2028 (USD Billion)
Chapter 7. Global Immuno Oncology Assays Market by Applications, 2018-2028 (USD Billion)
Chapter 8. Global Immuno Oncology Assays Market by Region, 2018-2028 (USD Billion)
Chapter 9. Company Profiles
Chapter 10. Appendix
Access research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html
Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Account Manager - Global
3131 McKinney Ave Ste 600
Dallas, TX 75204
Email ID: firstname.lastname@example.org
Phone No.: +1 972-362 -8199
Connect with us: Facebook | Twitter | LinkedIn